Denig Petra, van Puijenbroek Eugène P, Soliman Nashwa, Mol Peter G M, de Vries Sieta T
Department of Clinical Pharmacy and Pharmacology, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands.
Netherlands Pharmacovigilance Centre Lareb, 's-Hertogenbosch, The Netherlands.
Pharmacoepidemiol Drug Saf. 2019 Sep;28(9):1175-1179. doi: 10.1002/pds.4839. Epub 2019 Jun 17.
PURPOSE: Little is known about adverse drug events (ADEs) experienced over time during chronic drug use. The purpose of this study was to assess ADE patterns experienced by patients with diabetes. METHODS: Patients who received an oral glucose-lowering drug completed a daily diary for 13 weeks. The diary asked for experienced symptoms and whether patients related these symptoms to any drug they used. Summaries of Product Characteristics were used to check whether the ADEs were known adverse drug reactions (ADRs) of the drugs used. Patterns of weekly occurring ADEs were assessed with descriptive statistics. RESULTS: We included 78 patients. Almost half of them reported at least one ADE (N = 36; 46%). In total, 80 ADEs were reported. Of these ADEs, 71 (90%) were known ADRs. ADEs lasted less than 1 week in 27 cases (34%) and between 2 and 12 weeks in 15 cases (19%). The remaining ADEs fluctuated (16 cases; 20%) or persisted (22 cases; 28%) during the entire study period. CONCLUSIONS: ADEs experienced by patients with diabetes can fluctuate or persist over long periods of drug use.
目的:关于长期使用慢性药物期间发生的药物不良事件(ADEs),我们了解甚少。本研究的目的是评估糖尿病患者经历的ADEs模式。 方法:接受口服降糖药物治疗的患者完成了为期13周的每日日记。日记询问了所经历的症状以及患者是否将这些症状与他们使用的任何药物相关联。使用产品特性摘要来检查这些ADEs是否为所用药物已知的药物不良反应(ADRs)。采用描述性统计评估每周发生的ADEs模式。 结果:我们纳入了78名患者。其中近一半报告了至少一种ADE(N = 36;46%)。总共报告了80起ADEs。在这些ADEs中,71起(90%)是已知的ADRs。27例(34%)ADEs持续时间少于1周,15例(19%)持续2至12周。其余的ADEs在整个研究期间波动(16例;20%)或持续存在(22例;28%)。 结论:糖尿病患者经历的ADEs在长期用药期间可能波动或持续存在。
Pharmacoepidemiol Drug Saf. 2019-9
Aust Health Rev. 2014-2
Health Qual Life Outcomes. 2014-8-13
Am J Med Qual. 2017
Int J Clin Pharmacol Ther. 2001-1
Pharmacotherapy. 2013-5-17
Health Qual Life Outcomes. 2014-8-13
Saudi Pharm J. 2013-2-24
Eur J Clin Pharmacol. 2014-5
Pharmacoepidemiol Drug Saf. 2012-8-30
Pharmacoepidemiol Drug Saf. 2011-6